Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 02 May 2025

Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice

in Respiratory Pharmacology

Rui Wang
Fan Yang
Ying Liu
Meiting Peng
Lu Yu
Qinhui Hou
Yuan Liu
Zhenshun Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506518

1,097 views

Original Research

Published on 28 Apr 2025

Androgen receptor inhibitor ameliorates pulmonary arterial hypertension by enhancing the apoptosis level through suppressing the Notch3/Hes5 pathway

in Respiratory Pharmacology

Jiayan Sun
Jiancheng Lin
Di Yin
Zetao Pan
Yuheng Ye
Yi Wang
Xiaowan Wang
Qiang Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572489

791 views

Correction

Published on 24 Apr 2025

Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting

in Respiratory Pharmacology

Min Qiang
Zhe Chen
Hongyang Liu
Junxue Dong
Kejian Gong
Xinjun Zhang
Peng Huo
Jingjun Zhu
Yifeng Shao
Jinazun Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591443

753 views

Original Research

Published on 08 Apr 2025

Sparstolonin B nano-formulation attenuates LPS-induced lung injury

in Respiratory Pharmacology

Qinghe Meng
Xiaojing Wang
Dandan Guo
Gary Zhang
Changying Shi
Adam Novak
Xiguang Yang
Juntao Luo
Robert N. Cooney

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532391

877 views

Case Report

Published on 04 Apr 2025

Case Report: A case of Felty’s syndrome with initial presentation of pleural effusion and subsequent Escherichia coli pyothorax

in Respiratory Pharmacology

Haifeng Yang
Weiqin Wang
Yongfeng Liu
Yibo Yang
Yiliang Su

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529621

742 views
1 citation

Original Research

Published on 03 Apr 2025

Spiraea prunifolia var. simpliciflora leaves ameliorate inflammatory responses and oxidative stress in PPE/LPS-induced chronic obstructive pulmonary disease mouse model

in Respiratory Pharmacology

Ba-Wool Lee
Ji-Hye Ha
Da-Hye Yi
Ju-Hong Kim
Seong-Hun Jeong
Hyeon Jin Lee
Yun-Hye Kim
Hyung-Jun Kwon
Ji-Young Park
Woo Sik Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501731

1,473 views

Original Research

Published on 14 Mar 2025

The impact of phthalates on asthma and chronic obstructive pulmonary disease: a comprehensive analysis based on network toxicology and molecular docking

in Respiratory Pharmacology

Ren Li
Bingqing Zheng
Yuqiong Zhang
Lu He
Chaomin Ren
Linlin Guan
Huan Yang
Jiayu Tian
Xingyi Chen
Dongxing Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566965

1,977 views

Original Research

Published on 05 Mar 2025

Rutin attenuates bleomycin-induced acute lung injury via miR-9-5p mediated NF-κB signaling inhibition: network pharmacology analysis and experimental evidence

in Respiratory Pharmacology

Fatema S. Alatawi
Awatif M. E. Omran
Eman Rashad
Omnia N. Abdel-Rahman
Ahmed F. Soliman

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1522690

1,190 views

Original Research

Published on 04 Mar 2025

Assessing medication adherence in adults with asthma and its effect on rescue therapy for exacerbations

in Respiratory Pharmacology

Yi Ling Eileen Koh
Kian Yong Kenny Chua
Ding Xuan Ng
Wai Keong Aau
Ngiap Chuan Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516062

856 views

Case Report

Published on 27 Feb 2025

Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report

in Respiratory Pharmacology

Zhe Zhao
Longbin Pang
Surui Liu
Jie Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443609

1,380 views
1 citation

Review

Published on 18 Feb 2025

Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting

in Respiratory Pharmacology

Min Qiang
Zhe Chen
Hongyang Liu
Junxue Dong
Kejian Gong
Xinjun Zhang
Peng Huo
Jingjun Zhu
Yifeng Shao
Jinazun Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516583

2,552 views

Editorial

Published on 14 Feb 2025

Editorial: Lung microbiome in health and disease

in Respiratory Pharmacology

Kurtis Francis Budden
Luigina Romani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565849

729 views
1 citation

Case Report

Published on 05 Feb 2025

A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1

in Respiratory Pharmacology

Pei Zhu
Qingming Sun
Sheng Xu
Wanhui Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1508558

1,007 views

Review

Published on 29 Jan 2025

Silicosis: from pathogenesis to therapeutics

in Respiratory Pharmacology

Bijun Yang
Xiaoman Liu
Cheng Peng
Xiangjing Meng
Qiang Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516200

4,097 views
2 citations

Mini Review

Published on 20 Jan 2025

The potential role of nanobodies in asthma therapy

in Respiratory Pharmacology

Baraa Khalid Salah Al-Sheakly
Fatemeh Saheb Sharif-Askari
Narjes Saheb Sharif-Askari
Jennifer E. Hundt
Rabih Halwani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1510806

1,873 views

Editorial

Published on 14 Jan 2025

Editorial: Methods in respiratory pharmacology 2023

in Respiratory Pharmacology

Nadia Milad
Giulio Cabrini
Maria Cordina

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527053

841 views